2025 HCPCS Code C9758
Blinded procedure for nyha class iii/iv heart failure; transcatheter implantation of interatrial shunt or placebo control, including right heart catheterization, trans-esophageal echocardiography (tee)/intracardiac echocardiography (ice), and all imaging with or without guidance (e.g., ultrasound, fluoroscopy), performed in an approved investigational device exemption (ide) study
TAGS: performed transcatheter class placebo imaging procedure implantation heart study interatrial guidance exemption approved echocardiography blinded investigational device right shuntShort Description | Blind interatrial shunt ide |
HCPCS Action Code | N - No maintenance for this code |
HCPCS Coverage Code | D - Special coverage instructions apply |
HCPCS Code Added Date | January 01, 2020 |
HCPCS Action Effective Date | July 01, 2020 |
HCPCS Pricing Indicator Code | 53 - Statute |
HCPCS Type Of Service Code | 2 - Surgery |
HCPCS Multiple Pricing Indicator Code | A - Not applicable as HCPCS priced under one methodology |
HCPCS Anesthesia Base Unit Quantity | 0 |
HCPCS Coverage Issues Manual Reference Section Number |
Check Similar HCPCS Codes
- C9445 - C-1 esterase, ruconest
- C9446 - Inj, tedizolid phosphate
- C9447 - Inj, phenylephrine ketorolac
- C9448 - Oral netupitant palonosetron
- C9449 - Inj, blinatumomab
- C9450 - Fluocinolone acetonide implt
- C9451 - Injection, peramivir
- C9452 - Inj, ceftolozane/tazobactam
- C9453 - Injection, nivolumab
- C9454 - Inj, pasireotide long acting
- C9455 - Injection, siltuximab
- C9456 - Inj, isavuconazonium sulfate
- C9457 - Lumason contrast agent
- C9458 - Florbetaben f18
- C9459 - Flutemetamol f18
- C9460 - Injection, cangrelor
- C9461 - Choline c 11, diagnostic
- C9462 - Injection, delafloxacin
- C9463 - Injection, aprepitant
- C9464 - Injection, rolapitant